Company intelligence / Profile preview

NCB Venture Capital

Fukuoka, Fukuoka, Japan

Ownership: Private
Employees: ~11
Development stage: Other

Overview

NCB Venture Capital is a Japan-based corporate venture capital firm within the Nishi-Nippon Financial Holdings group. Established in 2020 as a subsidiary of Nishi-Nippon City Bank, it manages startup-focused investment funds and provides equity financing and management support to ventures from seed through later stages. The firm focuses broadly on startups in the bank's operating area, especially Kyushu, rather than operating as a drug developer or healthcare company. Its portfolio includes companies across multiple sectors, with some healthcare-related investments, but NCB Venture Capital itself is an investor rather than a biotech, pharma, or healthcare operating company.

Industry: Investors

Partnerships

QB Capital (co-manager of QB No. 2 Investment Limited Partnership)

Beyond the preview

Go deeper on NCB Venture Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NCB Venture Capital.

Explore the full profile